E O’Brien

6.2k citations

96 papers · 4.0k indexed · 1 hit paper · h-index 30

Biomaterials top 2%
Cardiology and Cardiovascular Medicine top 2%
- Blood Pressure and Hypertension Studies 16
- Heart Rate Variability and Autonomic Control 6
- Cardiovascular Health and Disease Prevention 6
Oncology top 5%
- Cancer Treatment and Pharmacology 5
- Lung Cancer Research Studies 5
Cancer Research top 5%
- Protease and Inhibitor Mechanisms 6
Pulmonary and Respiratory Medicine top 5%
- Lung Cancer Treatments and Mutations 9
- Lung Cancer Diagnosis and Treatment 6

Co-authors: Craig Tendler Stephen P. Ackland D G Kieback Piotr Tomczak Eva‐Maria Grischke F. Orlandi Armando Santoro L. Mellars
Cited by: Biomaterials Cardiology and Cardiovascular Medicine Oncology
Journals: Annals of Oncology (11 papers)Lung Cancer (4 papers)American Journal of Hypertension (3 papers)
Partner nations: Ireland United Kingdom United States

In The Last Decade

E O’Brien

94 papers receiving 3.8k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by E O’Brien

Since Specialization

Citations

This map shows the geographic impact of E O’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E O’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E O’Brien more than expected).

Fields of papers citing papers by E O’Brien

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E O’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E O’Brien. The network helps show where E O’Brien may publish in the future.

Co-authorship network

The 25 scholars most cited alongside E O’Brien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E O’Brien Line = papers co-authored together E O’Brien links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	120MO Adjuvant pembrolizumab versus placebo for early-stage NSCLC after resection and optional chemotherapy: Updated results from PEARLS/KEYNOTE-091 Immuno-Oncology Technology ·Benjamin Besse,Libor Havel,Solange Peters,Sandrine Marréaud,Μ. P. Streck,Kersti Oselin,Emilio Esteban,А.Ю. Зубов,Alex Martínez‐Martí,Martin Faehling,JS Lee,Yun Luo,S.M. Keller,Urania Dafni,M. Mauer,Imogen Stringer,E O’Brien,Masahiro Tsuboi,L. Paz-Ares	2023	7
2	VP3-2022: Pembrolizumab (pembro) versus placebo for early-stage non-small cell lung cancer (NSCLC) following complete resection and adjuvant chemotherapy (chemo) when indicated: Randomized, triple-blind, phase III EORTC-1416-LCG/ETOP 8-15 – PEARLS/KEYNOTE-091 study Annals of Oncology ·L. Paz-Ares,E O’Brien,M. Mauer,Urania Dafni,Kersti Oselin,Libor Havel,Emilio Esteban,Dolores Isla,Alex Martínez‐Martí,Martin Faehling,Masahiro Tsuboi,JS Lee,Kouichi Nakagawa,Jiong Yang,S.M. Keller,Μ. P. Streck,Sandrine Marréaud,Imogen Stringer,Solange Peters,Benjamin Besse	2022	49
3	Integrating hospital and community care: using a community virtual ward model to deliver combined specialist and generalist care to patients with severe chronic respiratory disease in their homes Irish Journal of Medical Science (1971 -) ·Breda Cushen,M. Pierre,Grover Bloomfield,George Seroka,E O’Brien,Deirdre Carroll,Sean Casserley,朱通华 Zhu Tonghua,R MAZZANTI,Sang-Hee Yoo,T Geffen,Karolina Farrell,Richard W. Costello,Clare Lewis	2021	5
4	The Royal College of surgeons multidisciplinary guidelines on elective tracheostomy insertion in COVID-19 ventilated patients The Surgeon ·Chen‐Hui Shen,N. B. Whittemore,Peter Walshe,Michael Walsh,Fergal Glynn,Peter D. Lacy,W. Karapetian,R. M. Walsh,Takuo Yasuda,James O’Rourke,Ross Morgan,E O’Brien,Neville Shine,Gerard F. Curley,James P. O’Neill	2020	7
5	An integrated multidisciplinary model of COVID-19 recovery care Irish Journal of Medical Science (1971 -) ·Helen O’Brien,Roma Magliano,Laouali Karimoune,E O’Brien,Ross Morgan,Richard W. Costello,Cedric Gunaratnam,D Ryan,Noel G. McElvaney,Samuel McConkey,Cora McNally,Gerard F. Curley,Siobhán MacHale,乔为平,Niall Pender,Helen Barry,Eoghan de Barra,Fiona Kiernan,Imran Sulaiman,Killian Hurley	2020	47
6	Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19) Thorax ·Shunyuan Zheng,Sinéad Toomey,Stephen F. Madden,Michelle Casey,Oscar S. Breathnach,Patrick G. Morris,Liam Grogan,Peter Branagan,Richard W. Costello,Eoghan de Barra,Killian Hurley,Cedric Gunaratnam,Noel G. McElvaney,E O’Brien,Imran Sulaiman,Ross Morgan,Bryan T. Hennessy	2020	57
7	BAL Cell Gene Expression in Severe Asthma Reveals Mechanisms of Severe Disease and Influences of Medications American Journal of Respiratory and Critical Care Medicine ·Nathaniel M. Weathington,E O’Brien,Josiah E. Radder,Thomas Whisenant,Eugene R. Bleecker,William W. Busse,Serpil C. Erzurum,Benjamin Gaston,Annette T. Hastie,Nizar N. Jarjour,Deborah A. Meyers,Jadranka Milošević,Wendy C. Moore,John Tedrow,John B. Trudeau,Rosaly Lee Ortiz,Wei Wu,Naftali Kaminski,Sally E. Wenzel,Brian D. Modena	2019	37
8	Prolonged Cold Ischemia Induces Necroptotic Cell Death in Ischemia–Reperfusion Injury and Contributes to Primary Graft Dysfunction after Lung Transplantation American Journal of Respiratory Cell and Molecular Biology ·Xingan Wang,E O’Brien,繁花岡,Che Xu,Qiang Zhang,Songjian Lu,Lifan Liang,Xiaojing An,John F. McDyer,Rama K. Mallampalli	2019	38
9	FBXO17 promotes cell proliferation through activation of Akt in lung adenocarcinoma cells Respiratory Research ·Tomeka Suber,Moisés Sihuincha M,E O’Brien,J.D. Londino,Jing Zhao,Kong Chen,Rama K. Mallampalli,Yutong Zhao	2018	25
10	Central nervous system (CNS) disease during trastuzumab emtansine (T-DM1) for HER2 positive advanced breast cancer (ABC): A single institution experience Annals of Oncology ·E. Parisi,Nicholas C. Turner,Matthew H. Edney,I E Smith,E O’Brien,Marina Parton,Alexander Ring,J. Alison Noble,Amanda Ip,Navita Somaiah,Komel Khabra,Alicia Okines	2016	1
11	Abnormal levels of heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) in tumour tissue and blood samples from patients diagnosed with lung cancer Molecular BioSystems ·Paul Dowling,浩輔西村,Annemarie Larkin,Michael Henry,Paula Meleady,Kathy Gately,Kenneth J. O’Byrne,Martin P. Barr,Vincent J. Lynch,Jo Ballot,John Crown,M. Moriarty,E O’Brien,Ross Morgan,Martin Clynes	2014	26
12	A 76 year old female diagnosed with cystic fibrosis. PubMed ·E O’Brien,Ade Ayu Agustin,Barry J. Plant	2014	0
13	Twenty-four-hour ambulatory blood pressure measurement in clinical practice and research: a critical review of a technique in need of implementation Journal of Internal Medicine ·E O’Brien	2011	54
14	A randomised trial in malignant mesothelioma (M) of early (E) versus delayed (D) chemotherapy in symptomatically stable patients: the MED trial Annals of Oncology ·E O’Brien,David Watkins,Ilaria Casella,K. Priest,Catherine M. Corbishley,A. Norton,S. Ashley,N.P. Rowell,R. Drew Sayer	2005	84
15	Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancerbreakdown → Annals of Oncology ·E O’Brien,Nely Wigler,Moshe Inbar,R. Rosso,Eva‐Maria Grischke,Armando Santoro,Raphael Catane,D G Kieback,Piotr Tomczak,Stephen P. Ackland,F. Orlandi,L. Mellars,Leila Alland,Craig Tendler	2004	1311
16	An intensive phenotyping study to enable the future examination of genetic influences on hypertension-associated cardiovascular disease Journal of Human Hypertension ·Alice Stanton,D Fitzgerald,Alun D. Hughes,Jamil Mayet,E O’Brien,N. Poulter,P S Sever,Denis C. Shields,Simon Thom	2001	11
17	Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British Hypertension Society BMJ ·E O’Brien	2000	351
18	The endodermal sinus tumour and clear cell ovarian cancer Annals of Oncology ·E O’Brien,Timothy Perren,Sylvia Tan,Cyril Fisher,E. Wiltshaw	1994	2
19	Accuracy of indirect blood pressure measurement in the elderly. BMJ ·土志田正二,Desmond J. Fitzgerald,K O'Malley,E O’Brien	1983	36
20	In search of Korotkoff. BMJ ·M. S. Laher,E O’Brien	1982	17

About E O’Brien

E O’Brien is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Oncology, Molecular Medicine and Cancer Research, having authored 96 papers that have together received 4.0k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (16 papers), Lung Cancer Treatments and Mutations (9 papers), Protease and Inhibitor Mechanisms (6 papers), Heart Rate Variability and Autonomic Control (6 papers), Lung Cancer Diagnosis and Treatment (6 papers), Cardiovascular Health and Disease Prevention (6 papers), Cancer Treatment and Pharmacology (5 papers) and Lung Cancer Research Studies (5 papers). The work is most often cited by research in Biomaterials (650 citations), Cardiology and Cardiovascular Medicine (1.1k citations), Oncology (863 citations), Cancer Research (353 citations) and Pulmonary and Respiratory Medicine (724 citations). E O’Brien has collaborated with scholars based in Ireland, United Kingdom and United States. Frequent co-authors include Craig Tendler, Stephen P. Ackland, D G Kieback, Piotr Tomczak, Eva‐Maria Grischke, F. Orlandi, Armando Santoro, L. Mellars, Moshe Inbar and Leila Alland. Their work appears in journals such as Annals of Oncology, Lung Cancer, American Journal of Hypertension, British Journal of Cancer and Thorax.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact